Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc (NQ: MASS )

5.640 -0.030 (-0.53%)
Streaming Delayed Price Updated: 3:52 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 222,789
Open 5.860
Bid (Size) 5.630 (6)
Ask (Size) 5.650 (5)
Prev. Close 5.670
Today's Range 5.600 - 6.070
52wk Range 4.850 - 12.51
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024
MASS stock results show that 908 Devices beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
-43.15%
-43.15%
1 Month
-14.67%
-14.67%
3 Month
-21.78%
-21.78%
6 Month
-10.48%
-10.48%
1 Year
-13.89%
-13.89%

More News

Read More
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
From 908 Devices Inc.
Via Business Wire
908 Devices Earnings Preview
Via Benzinga
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
From 908 Devices Inc.
Via Business Wire
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
Via Benzinga
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
Earnings Scheduled For March 5, 2024
Via Benzinga
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
From 908 Devices Inc.
Via Business Wire
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
Via The Motley Fool
3 Russell 2000 Stocks That Are About to Get Absolutely Crushed
Via InvestorPlace
908 Devices Announces MX908 Integration Capabilities
From 908 Devices Inc.
Via Business Wire
908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System
From 908 Devices Inc.
Via Business Wire
12 Information Technology Stocks Moving In Monday's Intraday Session
Via Benzinga
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Third Quarter Financial Results on November 7, 2023
From 908 Devices Inc.
Via Business Wire
908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program
From 908 Devices Inc.
Via Business Wire
908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters
From 908 Devices Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.